Get it on Google Play

Genzyme (GENZ) Withdraws Bioenvision's European Filing of Evoltra in Elderly AML Patients

March 19, 2008 12:03 PM EDT Send to a Friend
Genzyme Corp. (Nasdaq: GENZ) announced the withdrawal of the European application to extend the Evoltra product label to include ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login